Morpho-biological diversity of Trypanosoma cruzi has been known since Chagas' first works
in 1909. Several further studies confirmed the morphological differences among the parasite …

Determining the activity of a compound and the potential impact on a diseased state is
frequently undertaken using phenotypic or target-based approaches. Phenotypic screens …

Intracellular parasites such as Trypanosoma cruzi need to acquire valuable carbon sources
from the host cell to replicate. Here, we investigated the energetic metabolism of T. cruzi …

Trypanosoma cruzi, responsible for Chagas disease, is a serious public health problem in
Latin America with eight million people infected in the world. Clinical manifestations …

Past and more recent research has examined the ultrastructure, metabolism, cell biology,
genomics and post-genomics of schistosome schistosomula. These areas are considered …

The treatment for both leishmaniasis and trypanosomiasis, which are severe human
infections caused by trypanosomatids belonging to Leishmania and Trypanosoma genera …

The impact of trypanosomatid parasites on honeybee health may represent a major threat to
bee colonies worldwide. However, few axenic isolates have been generated to date and …

Chagas Disease, caused by the protozoan parasite Trypanosoma cruzi, affects nearly eight
million people in the world. T. cruzi is a complex taxon represented by different strains with …

In this paper, we aimed to explore the effects of the calpain inhibitor III (MDL28170) and to
detect calpain-like molecules (CALPs) in epimastigote forms of Trypanosoma cruzi isolate …

Trypanosoma cruzi parasites causing Chagas disease are passed between mammals by
the triatomine bug vector. Within the insect, T. cruzi epimastigote-stage cells replicate and …